Company Profile

I. Company Overview

Founded in July 1998 with a registered capital of 12 million yuan, our company specializes in the production and R&D of pharmaceutical desiccants, deoxidizers, and indicators, primarily for use in pharmaceuticals, biopharmaceuticals, medical devices, and related products. Our company is located at: Building 2, Unit A, 4th Floor, No. 499 Kangyi Road, Pudong New Area, Shanghai.

Following a joint review conducted by the Shanghai Municipal Science and Technology Commission and the Shanghai Municipal Commission of Economy and Information Technology, the company was consecutively recognized as a “Shanghai High-Tech Enterprise” in November 2020 and December 2023. In August 2022, the company was awarded the title of “Shanghai Specialized, Fine, and New Enterprise.” Currently, the company holds 21 CDE registration numbers, of which 13 are in active (A) status, achieving full product coverage in the field of pharmaceutical desiccants. The company also owns 3 Chinese invention patents, 1 U.S. patent, and 1 Japanese patent, as well as 4 U.S. DMF sales licenses—all of which are currently active. (For details, please refer to the attached documents: relevant supporting evidence.)

Through continuous market development, as of 2024, our company has established collaborations with over a thousand pharmaceutical companies and maintains close interactions with more than a hundred drug R&D institutions (averaging over 10 product licensing agreements per month), and we are still expanding our reach.

II. Basic Information on Production and Quality Control

In accordance with the “Pharmaceutical GMP” standards and relevant national regulations governing pharmaceutical packaging materials, the company’s pharmaceutical desiccant production workshop is strictly operated in compliance with the current national “Class D” standard for pharmaceutical packaging material production environments. The company’s established routine testing laboratory, analytical instrument room, microbiological testing laboratory, and equipped experimental instruments fully meet the quality-testing requirements for approved products and play a critically important role.

III. Future Development

In a market environment where labor costs have been rising year after year, Shanghai Yingqi has consistently maintained positive growth, largely thanks to its ongoing R&D and innovation capabilities, which enable it to continuously develop new products. Yingqi has broken the monopoly held by the U.S., Japan, Europe, and other regions over adsorbent materials such as pharmaceutical desiccant packaging and indicators. Yingqi is also increasingly committed to replacing imports with domestically produced alternatives. Not only has this helped refine the supply chains of domestic enterprises and indirectly reduced production costs, but it has also made a meaningful contribution to improving people’s livelihoods.